期刊文献+

固定点处组间生存率比较的统计检验法 被引量:6

Statistical methods for comparing survival rates at a fixed time point
原文传递
导出
摘要 组间生存曲线的比较是研究疾病预后的重要内容,目前常用Log-rank检验,但当生存曲线交叉或者两曲线后期开口较大,即比例假设不成立时,采用该法则失效。为此本文讨论适用这种情形的比较法。介绍两条生存曲线某固定点处生存率比较的5种(经典法、对数转换法、cloglog转换法、反正弦转换法和logit转换法)统计检验方法。通过实例分析发现,若用组间生存曲线整体检验的Log-rank检验法或Two-stage检验法均很难对两组生存率比较给出合理的结果,而选取几个固定点进行检验时,可得到固定时间点上组间生存率差异是否有统计学意义。在5种固定点时刻的检验方法中,以cloglog转换法最佳。 Comparison of survival curves between two groups is an important part of disease prognosis study. Log-rank test is commonly used, but when the two curves' later intersecting opening is too large, the proportion of assumptions is not established, thus the Log-rank test is ineffective. We introduces five statistical tests to compare two survival curves at a fixed time points: classic method, logarithmic transformation, cloglog transformation, arcsine transformation and logit transformation. Through the study we found that if the overall survival curves are difficult to compare between groups tested with Log-rank test method or Two-stage test method, the fixed time point test can effectively determine whether there was significant difference in survival rate at a fixed time point. Among the five fixed time ooint tests, cloglog transformation could give more precise result.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2015年第2期186-188,共3页 Chinese Journal of Epidemiology
基金 国家自然科学基金(81202288) 广州市科技计划(2012J5100023) 高等学校博士学科点专项科研基金(20114433120010) 广东省大学创业创新训练计划(1212113039)
关键词 生存曲线 组间生存率比较 Kaplan-Meier估计 固定点 Survival curves Comparison of survival rates between groups Kaplan-Meierestimate Fixed time point
  • 相关文献

参考文献9

  • 1Klein JP, Moeschberger ML. Survival analysis : techniques for censored and truncated data. 2nd ed [ M ]. New York(NY) : Springer, 2003.
  • 2Grambsch P, Themeau T. Proportional hazards tests and diagnostics based on weighted residuals [J ]. Biometrika, 1994,81 : 515-526.
  • 3李慧敏,韩栋,陈征,陈平雁,Nakamura Tsuyoshi.生存曲线交叉时统计推断方法的比较和选择[J].中国卫生统计,2013,30(5):668-672. 被引量:7
  • 4Weeda VB, Murawski M, McCabe AJ, et al. Fibrolamellar variant of hepato-cellular carcinoma does not have a better survival than conventional hepato-cellular carcinoma-Results and treatment recommendations fi'om the Childhood Liver Tumour Strategy Group (SIOPEL) experience [ J ]. Eur J Cancer, 2013,49 ( 12 ) : 2698-2704.
  • 5Klein JP, Logan B, Harhoff M, et al. Analyzing survival curves at a fixed point in time [J]. Stat Med,2007,26:4505-4519.
  • 6项永兵,高玉堂,金凡,杨工,孙璐.生存率置信区间的五种估计方法[J].中华流行病学杂志,1995,16(5):306-309. 被引量:3
  • 7Borgan O, Liestol K. A note on confidence intervals and bands for the survival curve based on transformations [J]. Scand J Stat, 1990,17:35-41.
  • 8Lagakos SW. Time-to event analyses for long-term treatments-the APPROVe trail [J]. N Engl J Med, 2006,355 : 113-117.
  • 9Royston P, Mahesh KBP. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt [J]. Stat Med, 2011.30(19):2409-2421.

二级参考文献11

  • 1项永兵,中国肿瘤情报,1991年,2卷,32页
  • 2Gehan EA. A generalized wilcoxon test for comparing arbitrarily singly- censored samples. Biomewika, 1965,52(1-2) :203-223.
  • 3Tarone RE,Ware JH. On distribution-free tests for equality of survival distributions. Biometrika, 1977,64 ( 1 ): 156-160.
  • 4Klein JP, Moeschberger ML. Survival analysis. Second Edition. New York, Snrinuer,2003.
  • 5Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chem- otherapy as first-line treatment for European patients with advanced EG- FR mutation-positive non-small-cell lung cancer (EURTAC) :a multi- centre, open-label, randomised phase 3 trial. The Lancet Oncology, 2012,13 (3) :239-246.
  • 6Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infec- tion in Botswana: a randomised, double-blind, placebo-controlled trial. The Lancet ,2011,377 (9777) : 1588-1598.
  • 7Gill RD. Censoring and stochastic integrals. Mathematical Centre Tracts. Amsterdam : Mathematisch Centrum, 1980 : 124.
  • 8Lin X, Wang HK. A new testing approach for comparing the overallhomogeneity of survival curves. Biometrical Journal ,2004,46 (5) :489- 496.
  • 9Qiu PH, Sheng J. A two-stage procedure for comparing hazard rate functions. Journal of the Royal Statistical Society Series B, 2008,70 (1) :191-208.
  • 10Burton A, Altman DG, Royston P, et al. The design of simulation stud- ies in medical statistics. Statistics in Medicine, 2006,25 ( 24 ) : 4279- 4292.

共引文献8

同被引文献39

  • 1李莹,章剑,朱爱萍,刘娟.2012—2013年江苏省江阴市新发恶性肿瘤生存率分析[J].中国肿瘤,2020,29(4):241-245. 被引量:18
  • 2项永兵,高玉堂,金凡,杨工,孙璐.生存率置信区间的五种估计方法[J].中华流行病学杂志,1995,16(5):306-309. 被引量:3
  • 3Klein JP, Moeschberger ML. Survival Analysis:Techniques for Cen- sored and Truncated Data. Second Edition. New York: Springer, 2003.
  • 4Grambsch P, Therueau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrics, 1994,81 ( 3 ) : 515-526.
  • 5Li H, Han D, Hou Y, et al. Statistical Inference Methods for Two Crossing Survival Curves:A Comparison of Methods. PLoS ONE, 2015,10( 1 ) :e0116774.
  • 6Logan BR, Klein JP, Zhang M. Comparing Treatments in the Presence of Crossing Survival Curves : An Application to Bone Marrow Trans- plantation. Biometrics ,2008,64 ( 3 ) :733-740.
  • 7Bresalier RS, Sandier RS, Quan H, et al. Cardiovascular Events Asso- ciated with Rofecoxib in a Colorectal Adenoma Chemoprevention Tri- al. N Engl J Med,2005,352( 11 ) :1092-1102.
  • 8Royston P ,Mahesh KBP. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Statistics in Medicine, 2011,30(19) :2409-2421.
  • 9庄爱华,甘可建,柳青,钱朝南.肿瘤学研究论文中的生存曲线图谬误辨析[J].编辑学报,2008,20(6):491-492. 被引量:1
  • 10项永兵.肿瘤流行病学研究资料的统计分析 第二讲 生存率置信区间估计和比较[J].中华流行病学杂志,1998,19(4):240-243. 被引量:7

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部